The glomerular layer of the olfactory bulb (OB) contains synaptic connections between olfactory sensory neurons and OB neurons as well as connections among OB neurons. A subpopulation of external tufted cells and periglomerular cells (juxtaglomerular neurons) expresses dopamine, and recent reports suggest that dopamine can inhibit olfactory sensory neuron activation of OB neurons. In this study, whole-cell electrophysiological and primary culture techniques were employed to characterize the neuromodulatory properties of dopamine on glutamatergic transmission between rat OB mitral/tufted (M/T) cells and interneurons.
inhibits excitatory neurotransmission between M/T cells and interneurons via a presynaptic mechanism.
Introduction
Although many aspects of dopamine in the olfactory bulb (OB) have been characterized over the past few decades, much remains to be understood about the role(s) of dopamine in olfactory information processing. It has been known for some time that subpopulations of both periglomerular neurons in the glomerular layer and tufted cells in the superficial external plexiform layers of the OB express tyrosine hydroxylase (TH), the rate-limiting enzyme for the synthesis of dopamine (Halasz et al. 1981) . Other investigators have characterized the laminar and cellular expression of both D1 and D2 dopamine receptor subtypes in the OB (Coronas et al. 1997; Koster et al. 1999; Levey et al. 1993) .
Olfactory experience has a significant effect on the expression of TH, OB dopamine content, and D2 receptors. After unilateral naris occlusion, TH and dopamine content decreases sharply (Baker et al. 1983 ) and D2 receptor expression dramatically increases (Guthrie et al. 1991) . Behavioral experiments have shown that D1 receptor activation improved odor detection performance (Doty et al. 1998) . Conversely, D2 receptor activation diminished odor detection performance in another series of experiments (Doty and Risser 1989) .
Using electrophysiological techniques, other investigators have shown that dopamine reduces evoked potentials in mitral cells from the turtle OB (Nowycky et al. JN-01058-2002 JN-01058- R1 4 1983 ) and the rat OB (Ennis et al. 2001) . Furthermore, the reduction in endogenous dopamine caused by naris closure augments both the number of mitral cells that respond to an individual odorant and the number of odorants to which an individual mitral cell will respond upon odor presentation to the reopened naris (Wilson and Sullivan 1995) .
Recent electrophysiological studies have shed some light on the synaptic mechanisms underlying these effects. D2 receptor activation on the presynaptic terminal of olfactory receptor neurons (ORNs) decreases the probability of glutamate release; hence, excitability of mitral/tufted (M/T) cells is diminished (Berkowicz and Trombley 2000; Ennis et al. 2001; Hsia et al. 1999 ). Also, activation of different dopamine receptor subtypes on M/T cells (D2) and interneurons (D1) mediates differential yet complementary transduction cascades with the overall effect of increasing GABAergic inhibition of M/T cells (Brunig et al. 1999 ).
In the present study, we combined patch-clamp electrophysiological recording with primary culture techniques to further identify the synaptic effects of dopamine. Our results suggest that dopamine may contribute to odor information processing through presynaptic inhibition of excitatory synaptic transmission between M/T cells and interneurons.
Methods

Tissue culture
The procedure for preparing primary cultures of OB neurons is described in detail elsewhere (Trombley and Blakemore 1999) . Briefly, P1-P5 Sprague-Dawley rat pups were decapitated in accordance with the institutional guidelines of The Care and Use of Laboratory Animals approved by the National Institutes of Health and The Florida State University's Animal Care and Use Committee. OBs were removed, cut into 1-mm cubes, and enzymatically treated in a calcium-buffered papain solution for 1h at 37°C. The OBs were triturated with a fire-polished pipette until a single-cell suspension was achieved.
The cells (250,000 cells/dish) were plated in 35-mm culture dishes on a confluent monolayer of previously prepared OB astrocytes. The neuronal media was comprised of 95% Minimal Essential Medium (MEM, Gibco), 5% horse serum (Gibco), 6 g/L glucose, and a nutrient supplement (Serum Extender, Collaborative Research). Astrocyte layers were obtained by plating a suspension of OB cells in a 75-cm 2 flask containing 90%
MEM, 10% fetal calf serum, and 6 g/L glucose. Once confluent, the cells were resuspended enzymatically with 0.125% trypsin and plated onto 35-mm dishes coated with poly-L-lysine (30,000-70,000 MW, 10 µg/ml, Sigma). Addition of 10 -5 M cytosine-ß-D-arabinofuranoside (Sigma) to the media 1 day after plating the neurons prevented the overgrowth of astrocytes.
Neuronal Identity
Presumptive M/T and interneurons were identified based on the morphological, physiological, and immunohistochemical criteria established by Trombley and Westbrook (1990) . Briefly, the cultures contained morphologically distinct populations of neurons: a small number of large-diameter pyramidal-shaped neurons (20-40 µm soma) and a much larger population of small-diameter bipolar neurons (5-10 µm soma). 
Electrophysiology
Electrophysiological recordings were obtained at room temperature from OB neurons after 6-14 days in culture. The acquisition software (AxoData and AxoGraph, Axon Instruments) was run on a Macintosh G3 computer and used to control an AxoClamp 2B amplifier (Axon Instruments).
The 35-mm culture dishes functioned as the recording chambers and were perfused at 0.5-2.0 ml/min with a bath solution consisting of (mM): 162.5 NaCl, 2.5 KCl, 2 CaCl 2 , 10 HEPES, 10 glucose, 0 MgCl 2 , 1 µM glycine (pH 7.3, osmolarity 325 mOsm).
Patch electrodes were pulled from borosilicate glass to a final tip resistance of 4-6 MOhm and filled with a solution containing (mM): 145 KMeSO 4 or CsCl, 1 MgCl 2 , 10 HEPES, 5
Mg-ATP, 0.5 Mg-GTP, and 1.1 EGTA (pH 7.2, osmolarity 310 mOsm).
Drugs were diluted in bath solution and then applied via a gravity-fed f low-pipe perfusion system, comprised of a row of 600 µm-OD, square glass barrels. An electronic manipulator (Warner Instruments) controlled the position of the flow pipes, and pinch clamps regulated drug delivery. The efficiency of the solution delivery produced complete drug exchange within 100 ms. In the text and figures, "control" data represent cells perfused with bath solution. The drugs used in these experiments were dopamine, glutamate, tetrodotoxin (TTX), SKF 38393 (all from Sigma), and bromocriptine mesylate (from Tocris).
Spontaneous synaptic activity was recorded from interneurons in current-clamp mode. Quantitative analyses of the effects of dopamine and dopamine receptor agonists were done by comparing the number of excitatory postsynaptic potentials (EPSPs) during a 20-second interval that exceeded 5 mV before, during, and after drug application. and quantify an effect on calcium channels, 10 mM BaCl 2 was substituted for CaCl 2 in the experimental drug solutions. Tetrodotoxin (1 µM) was added to block sodium currents, and Cs-based intracellular solutions were used to block potassium currents.
Immunocytochemistry
Our immunocytochemical procedures were modified from previous protocols (Trombley and Westbrook 1990) . Primary neuronal cultures were rinsed 3 x 10 minutes with phosphate-buffered saline (PBS) and fixed for 30 minutes in 4% buffered formaldehyde, which was osmotically adjusted to 320 mOsm with sucrose. The cultures were then rinsed 3 x 10 minutes with PBS. To prevent nonspecific antibody binding, a blocking solution containing 10% normal donkey serum (NDS) or normal rabbit serum in PBS was added to each fixed culture for 10 minutes. The blocking solution was removed by rinsing 3 x 10 minutes with PBS. The primary antibody was diluted in PBS then added to the cultures to incubate for 24 hours at room temperature. The next day, the cultures were rinsed 3 x 10 minutes with PBS to remove the primary antibody. The secondary antibody also was diluted in PBS and then added to the cultures for 1 hour. After incubation, the secondary antibody was removed by washing 3 x 10 minutes with PBS.
All PBS was then removed, and coverslips were applied inside the culture dish using Aquamount (Fisher Scientific, Fairlawn, NJ). The primaries used were a mouse antityrosine hydroxylase monoclonal antibody (Chemicon International, Temecula, CA) at a 1:10000 dilution and a goat anti-D2 receptor polyclonal antibody (Santa Cruz Biotech, CA) at a 1:1000 dilution. The corresponding secondaries were a goat anti-mouse IgG conjugated to Cy3 (Jackson Immunoresearch, West Grove, PA) used at a 1:200 dilution for TH and a rabbit anti-goat IgG conjugated to AlexaFluor 568 (Molecular Probes, Eugene, OR) at a 1:3000 dilution for D2 receptors. The fluorescent images were acquired on a Leica DM-LFS microscope using OpenLab 3.0 software.
Statistics
All statistics were performed using GraphPad Prism version 3.00 (San Diego, CA). Data were analyzed using a one-way ANOVA with Newman-Keuls Multiple
Comparison posttest. All data are presented as the mean ± SEM.
Results
Tyrosine hydroxylase and D2 receptor expression in primary culture in the absence of olfactory sensory neuron innervation
Several studies have shown that innervation by olfactory sensory neurons is necessary to maintain both dopamine content (Kawano and Margolis 1982) and TH expression in OB juxtaglomerular cells (Baker et al. 1983; Brunjes et al. 1985; Cho et al. 1996) . To determine whether dopamine could be synthesized in our cultures in the absence of olfactory sensory neurons, immunocytochemical techniques were used to examine TH expression. TH was expressed in every culture dish examined (n = 7) ( Figure 1A ), independent of the age of the animal at dissection (P1 -P5) or time in vitro (7 -12 days). Approximately 1% of the neurons were immunoreactive for TH.
Immunocytochemical controls were prepared by omitting addition of the primary antibody in some cultures and by substituting NDS for primary antibody in others. No significant amount of secondary binding occurred in either situation. These results suggest that dopamine is likely synthesized in primary culture without innervation from the olfactory epithelium.
Although it has been suggested that the majority of OB dopamine D2 receptors are expressed in olfactory sensory terminals (Guthrie et al. 1991; Koster et al. 1999) , other studies support the notion that D2 receptors are expressed by OB neurons (Coronas et al. 1997; Levey et al. 1993; Mansour et al. 1990 ) and are functional (Brunig et al. 1999; Coronas et al. 1999) . To address this issue further, we used immunocytochemical techniques to determine whether D2 receptors are expressed by the cultures we examined electrophysiologically. The majority of OB neurons, including M/T cells ( Figure 1B ), were immunoreactive for D2 receptors. Neurons from control cultures, which were exposed to the secondary antibody but not the primary, were not immunoreactive. These results are consistent with our electrophysiological results in which the majority of OB neurons were sensitive to dopamine or the D2 receptor agonist, bromocriptine (see below).
Figure 1 near here
Dopamine inhibits spontaneous excitatory synaptic activity
To determine whether dopamine has any effect on excitatory synaptic transmission between OB neurons, whole-cell current-clamp recordings were obtained from interneurons before, during, and after dopamine (30 µM) application ( Figure 2 ). In
13 of the 14 cells tested, spontaneous excitatory activity in the interneuron was substantially inhibited during dopamine application. Dopamine reduced the number of excitatory synaptic events > 5 mV during a 20-second interval to 24.2 ± 7.2% of control.
The latency of recovery to baseline activity ranged from 10 seconds to 3 minutes. Figure   2 shows an example of the recovery latency. That the recovery was not instantaneous was likely due to the metabotropic nature of dopamine receptors and the duration necessary to inactivate the effects of second messengers. The effects of dopamine, bromocriptine, and SKF38393 on the excitatory synaptic event number were not statistically different from one another (P > 0.05). Like dopamine, both SKF38393 and bromocriptine exerted effects on both individual and compound EPSPs. 
Dopamine attenuates evoked EPSPs in interneurons
Dopamine could reduce spontaneous excitatory transmission as an indirect consequence of increasing spontaneous inhibitory transmission. That is, increasing inhibition onto excitatory neurons could reduce the probability of glutamate release from excitatory neurons. To eliminate this type of network effect as the basis of dopamine's actions on excitatory synaptic transmission, identified pre-and postsynaptic neurons were isolated by recording from monosynaptically coupled neuron pairs. After both a M/T cell and an interneuron were whole-cell patch -clamped, a suprathreshold positive current pulse was injected to evoke an action potential in the M/T cell. The amplitude and the kinetics of the subsequent EPSP evoked in the interneuron were then analyzed.
The group of traces in Figure 4 are representative data, consisting of reliable, time-locked EPSPs from an interneuron following an evoked action potential in a presynaptic M/T cell. In the presence of 30 µM dopamine, the peak amplitude of the EPSP decreased to 68 ± 7% of the control amplitude (n = 6, P < .001). Neither the 10-90% rise time of the EPSP nor the presynaptic action potential shape or amplitude were modified by dopamine (P > 0.05). Following dopamine removal, the amplitude of the EPSP recovered to control values ( Figure 4A ). As shown in Figure 4B , application of 1 µM bromocriptine, a D2 receptor agonist, mimicked the dopamine-mediated attenuation of EPSP amplitude (62 ± 4% of control, n = 5, P < .02). As with dopamine, the 10-90% rise time of the EPSP was not affected (P > 0.05). However, the neurons did not recover well from the effects of bromocriptine after washout, perhaps due to the very high binding affinity of bromocriptine for the D2 receptor (Coronas et al. 1999) . In contrast to the effects of D2 receptor activation, D1 receptor activation with the selective D1 receptor agonist SKF38393 (30 µM) did not significantly affect monosynaptic transmission (n = 8, P = 0.67), as shown in Figure 4C . SKF38393 also did not alter the 10-90% rise time of the EPSP (P > 0.05).
Figure 4 near here
Dopamine exerts no direct effect on the postsynaptic interneuron
We also wanted to determine whether the effects of dopamine on excitatory transmission were presynaptic, postsynaptic, or both. First, we examined the effects of dopamine on membrane resistance in the interneuron, since a decrease in postsynaptic membrane resistance would reduce the EPSP amplitude. Hyperpolarizing current injections (250 msec, 30-55 pA) were made in interneurons in current-clamp mode from a membrane potential of -60 mV. Flow-pipe application of 30 µM dopamine had no effect on the amplitude or kinetics of the resulting voltage deflection (n = 4, Figure 5A ).
This result suggests that dopamine neither directly opens nor closes ion channels in the postsynaptic cell membrane sufficiently to cause a measurable change in resistance.
Figure 5 near here
Dopamine has no direct effects on glutamate receptors
A second hypothesis is that dopamine reduces EPSP amplitude via inhibition of postsynaptic glutamate receptors. To test this hypothesis, interneurons were whole-cell
voltage-clamped at -65 mV, and a glutamate receptor-mediated current was evoked by flow-pipe application of 500 µM glutamate, a concentration that activates all subtypes of ionotropic glutamate receptors. Dopamine (30 µM) was then coapplied during the glutamate-evoked current. Dopamine had no effect on either the kinetics or amplitude of the glutamate-mediated current (n = 8, Fig 5B) . Potential effects of dopamine on glutamate receptors were further examined by comparing currents evoked by glutamate alone with currents evoked by the coapplication of glutamate and dopamine (Fig. 5C ).
(These traces are in contrast to the trace in 5B, in which dopamine was coapplied during the middle of a glutamate-evoked current). Under these conditions too, dopamine did not alter the glutamate-evoked current (Fig 5C, n=6) .
The possibility that prolonged exposure is required for dopamine to exert its effects was also tested. The initial current evoked by 500 µM glutamate served as a control. The neurons were then incubated in 100 µM dopamine for 15-20 minutes and glutamate was reapplied. Preincubation with dopamine did not affect the amplitude of the current evoked by glutamate (data not shown). This lack of evidence for postsynaptic modulation of glutamate-mediated excitation by dopamine suggests that the presynaptic M/T cell is the likely target of dopamine's action.
Dopamine inhibits calcium channel currents in M/T cells
Because calcium channel modulation is a common mechanism of action for presynaptic inhibition, the effect of dopamine on calcium channel currents in M/T cells also was examined. M/T cells were voltage clamped at -60 mV and stepped to 0 mV for 50 ms. For ease of analysis, 10 mM Ba was substituted for Ca to enhance the amplitude of the current. Sodium currents were blocked with 1 µM TTX, and potassium currents were blocked with intracellular Cs. As shown in Figure 6A , calcium channel currents were diminished to 30 ± 7% of control amplitudes (n = 8 of 11, P < .001) in the presence of 30 µM dopamine. Due to a combination of the rundown of calcium currents over time (which normally occurs with whole-cell recording) and possible lingering dopaminergic effects, the currents in the cells tested only recovered to 67% of their original amplitudes.
Application of 1 µM bromocriptine also attenuated calcium currents in M/T cells ( Figure   6B ). Bromocriptine diminished calcium currents to 66 ± 5% of the original amplitude, with subsequent recovery to 83% of the original current amplitude (n = 8 of 12, P < 0.001). Although dopamine and bromocriptine had similar effects on evoked EPSPs, dopamine had a greater effect on calcium channel currents. A potential explanation for this discrepancy is that dopamine activates additional dopamine receptors that also attenuate calcium channel currents. In contrast to dopamine and bromocriptine, the reduction in calcium channel currents in response to application of 30 µM SKF38393 was no greater than that expected from normal current rundown (n = 7; Figure 6C ).
To further identify the type of calcium channels affected by dopamine, 30 µM dopamine was applied after the L-type channels had been blocked by nifedipine (10-100 µM). Nifedipine alone reduced the calcium channel current to 64 ± 5% of control (n = 9, P < 0.01). Application of dopamine blocked the nifedipine-resistant calcium channel currents by 29 ± 7 % ( Figure 6D , n = 9, P < 0.001). These results suggest that dopamine can inhibit the dihydropyridine-resistant high-voltage calcium channels (N-and P/Qtype) previously implicated in transmitter release in the OB (Isaacson 2001; Isaacson and Strowbridge 1998) . The effects of nifedipine at 10 µM were near saturating and not significantly different those at 100 µM (data not shown). The degree of calcium channel current block at either 10 or 100 µM nifedipine was similar to the 40% block with 10 µM nifedipine previously observed in these neurons (Trombley, 1992) . 
Synaptic organization and dopamine neurons in the OB
The axons of the olfactory sensory neurons enter the OB and innervate periglomerular (PG) neurons, superficial tufted cells, and the primary dendrites of mitral cells within glomeruli. Each glomerulus is thought to operate as a functional unit, and each responds best to a specific group of odors (Mombaerts 1999) . The GABAergic PG neurons that circumscribe the glomeruli mediate feedback inhibition within glomeruli and lateral (feedforward) inhibition between glomeruli (Shepherd 1972). A large subset of PG cells is also dopaminergic (Gall et al. 1987; Kosaka et al. 1985) , as is a subpopulation of superficial tufted cells (Halasz et al. 1981) . The latter neurons make reciprocal Although it has been reported that olfactory nerve transection reduces TH and dopamine expression in the OB (B runjes et al. 1985) , the present study provides immunocytochemical evidence that there is significant expression of TH (and perhaps, dopaminergic transmission) in cultured neurons in the absence of olfactory sensory neuron input. The proportion of TH-immunoreactive neurons in our cultures is consistent with recent findings in cultured neurons (Cigola et al.,1998; Puche et al.,1999 ) and the intact bulb (McLean and Shipley, 1998). Cigola and colleagues reported that a 48-hour treatment with high external potassium concentrations, used to maintain membrane depolarization, increased baseline TH expression in mouse OB cultures 2.4 fold.
Application of an L-type calcium channel antagonist blocked this increase in expression (Cigola et al. 1998 ). Puche and colleagues reported that co-culturing rat OB cells with olfactory epithelium also caused a 2.4-fold increase in TH expression. Interestingly, they found that application of an NMDA receptor antagonist could block this effect. These data suggest that calcium influx is an important modulator of TH expression and that the route of calcium entry may be either through NMDA receptors or voltage-gated calcium channels.
Our use of astrocyte feeder layers promotes high neuronal survival and rapid formation of synaptic contacts. Given this, our data may suggest that ongoing spontaneous synaptic activation of NMDA receptors, and/or depolarization sufficient to activate voltage-gated calcium channels, is adequate to maintain levels of TH expression in culture similar to those observed in the intact bulb (McLean and Shipley, 1998) .
Alternatively, some expression of TH may be independent of these mechanisms.
Differentiation between these hypotheses awaits further experimentation.
Dopamine modulates neurotransmission
Previous reports have shown that dopamine can modulate neurotransmission in the OB. In the turtle OB, exogenous dopamine application both delayed the onset and where dopamine also decreases glutamatergic neurotransmission. However, the effects of dopamine on neurotransmission are not limited to excitatory transmission. For example, GABAergic inputs to the rat striatum are also sensitive to dopamine receptor-mediated inhibition (Delgado et al. 2000) . Dopamine also modulates inhibitory transmission of OB neurons in culture. Brunig et al (1999) reported that D1 receptor activation attenuates GABA-gated chloride currents in cultured interneurons and that stimulation of D2
receptors on cultured M/T cells potentiates GABA-gated chloride currents. These findings by Brunig and colleagues may explain why the D1 receptor agonist SKF38393 appeared to affect spontaneous activity in our experiments while not affecting other aspects of excitatory neurotransmission (e.g., evoked monosynaptic potentials, voltagegated calcium currents, membrane resistance). That is, a SKF38393-mediated reduction in inhibition of GABAergic interneurons, which could potentiate inhibition of M/T cells, could secondarily reduce spontaneous excitatory transmission.
Dopamine's effects may be mediated via inhibition of calcium channel currents
In the present experiments, as in most of the cited examples, the effects of dopamine appear to be presynaptic. This interpretation is based on our finding that dopamine did not directly affect postsynaptic membrane resistance nor directly inhibit postsynaptic glutamate-mediated currents. It is also supported by previous OB studies demonstrating that dopamine has no effect on M/T cell NMDA, AMPA, or kainate receptors (Berkowicz and Trombley 2000) , juxtaglomerular cell input resistance, or the amplitude of miniature excitatory postsynaptic currents (Ennis et al. 2001; Hsia et al. 1999 ). Furthermore, the possibility that postsynaptic effects on network behavior were indirectly mediating dopamine's effects on excitatory transmission (as might occur with recording of spontaneous activity) was eliminated by recording from monosynaptically coupled pairs of identified M/T cells and interneurons.
It has been demonstrated in the turtle that dopamine reduces calcium influx in olfactory sensory neuron terminals (Wachowiak and Cohen 1999) and that presynaptic D2 receptor activation inhibits glutamate release from these terminals (Berkowicz and Trombley 2000) . The fact that dopamine, or D2 receptor agonists, can reduce calcium channel currents evoked from presynaptic M/T cells lends further support to the notion that dopamine reduces excitatory transmission via reductions in glutamate release.
Dopamine may have had a greater effect on calcium channel currents than bromocriptine because dopamine activates all dopamine receptors (more than one of which may affect calcium channels) whereas bromocriptine is selective for D2 receptors. That dopamine and bromocriptine had similar effects on monosynaptic transmission suggests that dopamine's D2 effects on calcium channels is all that is necessary to account for This is not the first examination of calcium channel currents in cultured OB neurons. From a holding potential of -60 mV, we previously observed calcium currents in cultured M/T cells that activated near -40 mV, peaked at 0 mV, and reversed near +55 (Trombley, 1992; Trombley and Westbrook, 1992) . Transient or T-type currents were small and rarely observed, even from a holding potential of -100 mV where most T-type channels would be available for activation (Trombley, 1992; Trombley and Westbrook, 1992) .
Dopamine Receptors
The recently cloned dopamine receptors are typically grouped into either the D1 or D2 subfamily according to sequence homology and pharmacological attributes (Neve and Neve 1997; Sidhu and Niznik 2000) . These receptors have a distinct laminar and cellular distribution throughout the OB. In the rat, D1 receptors are found in the glomerular, external plexiform, mitral cell, internal plexiform, and granule cell layers, whereas D2 receptors are located in the olfactory nerve, glomerular, and external plexiform layers (Coronas et al. 1997; Levey et al. 1993; Mansour et al. 1990; Nickell et al. 1991) .
Although there is some controversy, several studies support the notion that M/T cells express D2 receptors. Although not specifically addressed in the text, autoradiographic in situ hybridization data presented by Mansour et al. (1990) suggest that D2 receptor mRNA is expressed in the mitral cell layer. Levey et al. (1993) The two receptor subtypes also tend to have a specific synaptic deposition (Brunig et al. 1999; Nickell et al. 1991) , which may allow dopamine to differentially modulate synaptic circuits. Results from the OB and other brain regions indicate that D2 receptors tend to play a presynaptic role and D1 receptors, a postsynaptic role, in neurotransmission (Hsu et al. 1995) . Our results are consistent with the general notion that D2 receptor activation can reduce transmitter release. In contrast to the effects of the D1 selective agonist SKF38393, the D2 selective agonist bromocriptine mimicked dopamine's inhibition of calcium channel currents and evoked EPSPs.
Significance to olfactory function
Olfactory experience has a significant effect on the concentration of both TH and dopamine within the OB (Baker et al. 1983) . Olfactory deprivation, from either unilateral olfactory nerve transection or unilateral naris occlusion, reduces OB dopamine content in the ispsilateral bulb by as much as 75% (Baker et al. 1983 ) and enhances bulb responsiveness to odors, as measured by single-unit recordings and 2-deoxyglucose autoradiography (Guthrie et al. 1990; Wilson and Sullivan 1995) . This enhanced responsiveness, as well as a decrease in odor discrimination, is mimicked by application of the D2 receptor antagonist, spiperone (Wilson and Sullivan 1995) . Other behavioral experiments have shown that activation of D1 or D2 receptors can increase or decrease the threshold for odor detection, respectively (Doty et al. 1998; Doty and Risser 1989) .
These results suggest that dopamine may contribute to both odor detection sensitivity and discrimination. Previous electrophysiological studies, along with the present study, may provide synaptic bases for these observations; these studies demonstrate that activation of presynaptic D2 
